188 related articles for article (PubMed ID: 25602259)
1. Emerging role of linker histone variant H1x as a biomarker with prognostic value in astrocytic gliomas. A multivariate analysis including trimethylation of H3K9 and H4K20.
Sepsa A; Levidou G; Gargalionis A; Adamopoulos C; Spyropoulou A; Dalagiorgou G; Thymara I; Boviatsis E; Themistocleous MS; Petraki K; Vrettakos G; Samaras V; Zisakis A; Patsouris E; Piperi C; Korkolopoulou P
PLoS One; 2015; 10(1):e0115101. PubMed ID: 25602259
[TBL] [Abstract][Full Text] [Related]
2. Histone Mark Profiling in Pediatric Astrocytomas Reveals Prognostic Significance of H3K9 Trimethylation and Histone Methyltransferase SUV39H1.
Klonou A; Korkolopoulou P; Gargalionis AN; Kanakoglou DS; Katifelis H; Gazouli M; Chlamydas S; Mitsios A; Kalamatianos T; Stranjalis G; Themistocleous MS; Papavassiliou KA; Sgouros S; Papavassiliou AG; Piperi C
Neurotherapeutics; 2021 Jul; 18(3):2073-2090. PubMed ID: 34296393
[TBL] [Abstract][Full Text] [Related]
3. Role of histone lysine methyltransferases SUV39H1 and SETDB1 in gliomagenesis: modulation of cell proliferation, migration, and colony formation.
Spyropoulou A; Gargalionis A; Dalagiorgou G; Adamopoulos C; Papavassiliou KA; Lea RW; Piperi C; Papavassiliou AG
Neuromolecular Med; 2014 Mar; 16(1):70-82. PubMed ID: 23943221
[TBL] [Abstract][Full Text] [Related]
4. H3K9me3, H3K36me3, and H4K20me3 Expression Correlates with Patient Outcome in Esophageal Squamous Cell Carcinoma as Epigenetic Markers.
Zhou M; Li Y; Lin S; Chen Y; Qian Y; Zhao Z; Fan H
Dig Dis Sci; 2019 Aug; 64(8):2147-2157. PubMed ID: 30788686
[TBL] [Abstract][Full Text] [Related]
5. Loss of histone H4K20 trimethylation predicts poor prognosis in breast cancer and is associated with invasive activity.
Yokoyama Y; Matsumoto A; Hieda M; Shinchi Y; Ogihara E; Hamada M; Nishioka Y; Kimura H; Yoshidome K; Tsujimoto M; Matsuura N
Breast Cancer Res; 2014 Jun; 16(3):R66. PubMed ID: 24953066
[TBL] [Abstract][Full Text] [Related]
6. Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma.
Chiba T; Saito T; Yuki K; Zen Y; Koide S; Kanogawa N; Motoyama T; Ogasawara S; Suzuki E; Ooka Y; Tawada A; Otsuka M; Miyazaki M; Iwama A; Yokosuka O
Int J Cancer; 2015 Jan; 136(2):289-98. PubMed ID: 24844570
[TBL] [Abstract][Full Text] [Related]
7. Cancer-associated upregulation of histone H3 lysine 9 trimethylation promotes cell motility in vitro and drives tumor formation in vivo.
Yokoyama Y; Hieda M; Nishioka Y; Matsumoto A; Higashi S; Kimura H; Yamamoto H; Mori M; Matsuura S; Matsuura N
Cancer Sci; 2013 Jul; 104(7):889-95. PubMed ID: 23557258
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of histone marks H3K27me3 and H3K9me3 and modifying enzymes EZH2, SETDB1 and LSD-1 in colorectal cancer.
Carvalho S; Freitas M; Antunes L; Monteiro-Reis S; Vieira-Coimbra M; Tavares A; Paulino S; Videira JF; Jerónimo C; Henrique R
J Cancer Res Clin Oncol; 2018 Nov; 144(11):2127-2137. PubMed ID: 30105513
[TBL] [Abstract][Full Text] [Related]
9. Histone trimethylation at H3K4, H3K9 and H4K20 correlates with patient survival and tumor recurrence in early-stage colon cancer.
Benard A; Goossens-Beumer IJ; van Hoesel AQ; de Graaf W; Horati H; Putter H; Zeestraten EC; van de Velde CJ; Kuppen PJ
BMC Cancer; 2014 Jul; 14():531. PubMed ID: 25047223
[TBL] [Abstract][Full Text] [Related]
10. Histone H3K9 methyltransferase SETDB1 overexpression correlates with pediatric high-grade gliomas progression and prognosis.
Klonou A; Korkolopoulou P; Giannopoulou AI; Kanakoglou DS; Pampalou A; Gargalionis AN; Sarantis P; Mitsios A; Sgouros S; Papavassiliou AG; Piperi C
J Mol Med (Berl); 2023 Apr; 101(4):387-401. PubMed ID: 36811655
[TBL] [Abstract][Full Text] [Related]
11. Aberrant histone methylation and the effect of Suv39H1 siRNA on gastric carcinoma.
Cai L; Ma X; Huang Y; Zou Y; Chen X
Oncol Rep; 2014 Jun; 31(6):2593-600. PubMed ID: 24737085
[TBL] [Abstract][Full Text] [Related]
12. HP1α is highly expressed in glioma cells and facilitates cell proliferation and survival.
Lai X; Deng Z; Guo H; Zhu X; Tu W
Cancer Biomark; 2017 Dec; 20(4):453-460. PubMed ID: 28946550
[TBL] [Abstract][Full Text] [Related]
13. High expression of H3K9me3 is a strong predictor of poor survival in patients with salivary adenoid cystic carcinoma.
Xia R; Zhou R; Tian Z; Zhang C; Wang L; Hu Y; Han J; Li J
Arch Pathol Lab Med; 2013 Dec; 137(12):1761-9. PubMed ID: 24283856
[TBL] [Abstract][Full Text] [Related]
14. Loss of histone H4K20 trimethylation occurs in preneoplasia and influences prognosis of non-small cell lung cancer.
Van Den Broeck A; Brambilla E; Moro-Sibilot D; Lantuejoul S; Brambilla C; Eymin B; Gazzeri S
Clin Cancer Res; 2008 Nov; 14(22):7237-45. PubMed ID: 18974389
[TBL] [Abstract][Full Text] [Related]
15. Effects of histone methyltransferase inhibitor chaetocin on histone H3K9 methylation of cultured ovine somatic cells and development of preimplantation cloned embryos.
Zhang YM; Gao EE; Wang QQ; Tian H; Hou J
Reprod Toxicol; 2018 Aug; 79():124-131. PubMed ID: 29909068
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemistry for histone h3 lysine 9 methyltransferase and demethylase proteins in human melanomas.
Miura S; Maesawa C; Shibazaki M; Yasuhira S; Kasai S; Tsunoda K; Maeda F; Takahashi K; Akasaka T; Masuda T
Am J Dermatopathol; 2014 Mar; 36(3):211-6. PubMed ID: 24658378
[TBL] [Abstract][Full Text] [Related]
17. Histone H1.0--a potential molecular marker with prognostic value for patients with malignant gliomas.
Gabrovsky N; Georgieva M; Laleva M; Uzunov K; Miloshev G
Acta Neurochir (Wien); 2013 Aug; 155(8):1437-42. PubMed ID: 23812966
[TBL] [Abstract][Full Text] [Related]
18. Histone methyltransferase Suv39h1 attenuates high glucose-induced fibronectin and p21(WAF1) in mesangial cells.
Lin SH; Ho WT; Wang YT; Chuang CT; Chuang LY; Guh JY
Int J Biochem Cell Biol; 2016 Sep; 78():96-105. PubMed ID: 27373678
[TBL] [Abstract][Full Text] [Related]
19. HP1α is highly expressed in glioma cells and facilitates cell proliferation and survival.
Lai X; Deng Z; Guo H; Zhu X; Tu W
Biochem Biophys Res Commun; 2017 Aug; 490(2):415-422. PubMed ID: 28623138
[TBL] [Abstract][Full Text] [Related]
20. NRF2, DJ1 and SNRX1 and their prognostic impact in astrocytic gliomas.
Haapasalo J; Nordfors K; Granberg KJ; Kivioja T; Nykter M; Haapasalo H; Soini Y
Histol Histopathol; 2018 Aug; 33(8):791-801. PubMed ID: 29441509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
